Boehringer Ingelheim: Arthritis, Rheumatoid trials
The registry lists 19 Arthritis, Rheumatoid studies with Boehringer Ingelheim as lead sponsor. 0 are open to participants now and 7 have results posted.
Phase 1 2Phase 2 4Phase 3 6No phase 7(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Long-term Assessment of Safety and Efficacy of BI 695501 in Patients With Rheumatoid ArthritisCompletedNCT02640612Phase 3Results posted
- Assessment of the Handling Experience With the BI 695501 Autoinjector in Patients With Rheumatoid Arthritis Followed by an Extension Phase Using BI 695501 Prefilled SyringeCompletedNCT02636907Phase 2Results posted
- BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid ArthritisCompletedNCT02137226Phase 3Results posted
- Safety and Efficacy of BI 695500 in Patients With Moderately to Severely Active Rheumatoid ArthritisTerminatedNCT01955733Phase 3Results posted
- Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effects of Multiple Rising Subcutaneous Doses of BI 655064 in Healthy Volunteers and in Rheumatoid Arthritis Patients With Prior Inadequate Response to Methotrexate TherapyCompletedNCT01751776Phase 1Results posted
- Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid ArthritisTerminatedNCT01682512Phase 3Results posted
- Assessing the Impact of MOVALIS in Osteoarthritis and Rheumatoid Arthritis Patients on Health Related Quality of LifeCompletedNCT00619177Results posted
- Developing a Screening Tool for Interstitial Lung Disease in People With Rheumatoid Arthritis Using Risk FactorsCompletedNCT05855109
- Efficacy and Safety of BIIL 284 BS in Adult Patients With Active Rheumatoid ArthritisCompletedNCT02251210Phase 2
- Pharmacokinetics, Safety and Efficacy of BIIL 284 BS in Patients With Rheumatoid Arthritis (RA)CompletedNCT02247375Phase 1
- Efficacy, Safety and Pharmacokinetics of BIRB 796 BS Tablets in Patients With Active Rheumatoid ArthritisTerminatedNCT02214888Phase 2
- Efficacy and Safety of Different Doses of BIRB 796 BS in Patients With Active Rheumatoid ArthritisCompletedNCT02209779Phase 2
- Observational Study of Meloxicam in Mexican Patients With Rheumatic DiseasesCompletedNCT02184065
- Safety and Efficacy of Mobic® Ampoules in the Initiation of Treatment of Painful Exacerbations of Osteoarthritis, Rheumatoid Arthritis and Other Similar Painful Inflammatory ConditionsCompletedNCT02184052
- Observational Study of Meloxicam in Any Labeled IndicationCompletedNCT02182739
- Safety and Efficacy of Meloxicam Compared to Other Nonsteroidal Antiinflammatory Drugs (NSAIDs) in an Observational Cohort Study of Patients With Rheumatoid Arthritis, Osteoarthritis, Lumbago, Scapulohumeral Periarthritis, Neck, Shoulder and Arm SyndromeCompletedNCT02180516
- Safety and Efficacy of Mobic Inj. (Meloxicam) for the Patients With OA or RA: Observational StudyCompletedNCT00612885
- A Study to Compare Meloxicam IM Once Daily Versus Meloxicam Orally Once Daily in Patients With Rheumatoid ArthritisCompletedNCT00239382Phase 3
- A Multi-Center Trial to Compare Three Doses of Meloxicam and Placebo in Patients With Rheumatoid ArthritisCompletedNCT00042068Phase 3